TCG
LLY icon

Transcendent Capital Group’s Eli Lilly LLY Stock Holding History

Transcendent Capital Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-195
Closed -$210K – 117
2025
Q4 		$210K Buy
+195
New +$186K 0.09% 114
2025
Q1 		– Sell
-196
Closed -$151K – 276
2024
Q4 		$151K Hold
196
– – 0.08% 113
2024
Q3 		$174K Sell
196
-33
-14% -$29.7K 0.09% 115
2024
Q2 		$207K Buy
229
+34
+17% +$27.2K 0.12% 85
2024
Q1 		$152K Hold
195
– – 0.09% 106
2023
Q4 		$114K Buy
+195
New +$114K 0.08% 101

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Transcendent Capital Group's LLY Position: Q1 2026 in Review

Transcendent Capital Group sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 195 shares — an estimated $210K sold.

Transcendent Capital Group first reported a position in LLY in Q4 2023 and held it in 6 quarters. The position peaked at $210K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Transcendent Capital Group reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Transcendent Capital Group sold 195 Eli Lilly shares in Q1 2026, an estimated $210K.
  • Transcendent Capital Group first reported a position in Eli Lilly in Q4 2023 and held it in 6 quarters.
  • Transcendent Capital Group's Eli Lilly position peaked at $210K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Transcendent Capital Group's 13F filing for Q1 2026, filed 27 Apr 2026.